- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Facioscapulohumeral Muscular Dystrophy Type 2 in Hong Kong
Total 310 results
-
SanofiTerminatedSleep Initiation and Maintenance DisordersUnited States, Canada, Brazil, Russian Federation, Australia, Germany, Italy, Spain, Turkey, India, Malaysia, Singapore, Belgium, Czech Republic, Mexico, Argentina, Austria, Colombia, Chile, South Africa, United Kingdom, Hong Kong
-
TheracosCompletedType 2 Diabetes MellitusUnited States, Japan, Czechia, Hungary, Poland, Spain
-
AstraZenecaTerminatedType 2 DiabetesBrazil, France, Russian Federation, South Africa, Germany, Malaysia, Finland, Norway, Hong Kong, Canada, Hungary, Portugal, Taiwan, India, Philippines, Switzerland, Indonesia, Singapore
-
Janssen Research & Development, LLCCompletedMultiple MyelomaKorea, Republic of, Malaysia, China, Taiwan, Hong Kong
-
Advanced-JJapan Heart FoundationUnknownHypertension | Diabetes Mellitus, Type 2Japan
-
Harbor TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
Medtronic DiabetesRecruitingType 2 Diabetes Treated With InsulinUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany, Poland, Russian Federation, Spain, Sweden, Netherlands, Singapore, Malaysia, France, Croatia, Romania, United Kingdom, Hong Kong
-
VA Office of Research and DevelopmentNational Eye Institute (NEI); SmithKline BeechamCompletedType 2 Diabetes MellitusUnited States, Puerto Rico
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Colombia, Russian Federation, Germany, Hungary, Italy, Mexico, Peru, Romania, Slovakia, Brazil, El Salvador
-
Eli Lilly and CompanyCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesKorea, Republic of, Japan, Malaysia, Taiwan, Thailand, Hong Kong
-
AmgenActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, Czechia, Taiwan, Canada, Japan, Korea, Republic of, Germany, Hungary, Australia, Hong Kong, Spain, Poland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan, Malaysia, Taiwan, Korea, Republic of, Hong Kong
-
University of SydneyNational Health and Medical Research Council, Australia; Mylan Pharmaceuticals... and other collaboratorsRecruitingDiabetic Retinopathy | Diabetic Nephropathies | Type 1 Diabetes MellitusAustralia, Hong Kong, New Zealand, United Kingdom
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2France, Poland, United Kingdom, United States, Spain, Colombia, India, Romania, South Africa, Ukraine, Australia, Canada, Greece, Sweden, New Zealand, Switzerland, Hong Kong
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedDiabetes MellitusChina, United States, Canada, Mexico, Russian Federation, Croatia, United Kingdom, Argentina, Australia, India, South Africa, Greece, Ukraine, Romania, Italy, Hong Kong, Former Serbia and Montenegro, Brazil
-
PhenomixUnknownType 2 Diabetes MellitusUnited States, Argentina, Canada, India, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTaiwan, Korea, Republic of, South Africa, Hong Kong, Brazil, China, Ukraine
-
HighTide Biopharma Pty LtdActive, not recruitingType 2 Diabetes | Nonalcoholic Steatohepatitis (NASH)United States, China, Hong Kong
-
PfizerCompletedDiabetic NephropathyUnited States, Spain, Korea, Republic of, Australia, Hong Kong, Germany, Poland, Italy, Canada, Puerto Rico, Malaysia, Romania, Argentina, Peru
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States
-
AstraZenecaCompletedType 2 Diabetes Mellitus, CKD and AlbuminuriaUnited States, Spain, Canada, Korea, Republic of, Mexico, Japan, Taiwan, Australia, South Africa
-
TakedaTerminatedType 2 Diabetes MellitusUnited States, Poland, Ukraine, Taiwan, Bulgaria, Romania, Slovakia
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Bangladesh, Belgium, Canada, China, Germany, Guatemala, Hong Kong, India, Lebanon, Mexico, Peru, Philippines, Spain, Taiwan
-
Regeneron PharmaceuticalsBayerActive, not recruitingType 2 Diabetes Mellitus | Diabetic Macular Edema | Type 1 Diabetes MellitusUnited States, Puerto Rico, Japan, United Kingdom, Canada, Czechia, Germany, Hungary
-
Intarcia TherapeuticsCompletedType 2 DiabetesFinland, United States, Bulgaria, Poland, South Africa, Denmark, Turkey, Slovakia, Germany
-
Eli Lilly and CompanyTerminatedDiabetes Mellitus, Type 2United States, Puerto Rico, Greece, Taiwan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Serbia, South Africa, Taiwan, Romania, Algeria, Hong Kong, Brazil, China, Czechia
-
Mannkind CorporationTerminated
-
Biomea Fusion Inc.RecruitingStudy of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)Type 2 Diabetes MellitusUnited States, Canada
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes MellitusUnited States, Argentina, India, Peru, Poland, Czech Republic
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, Russian Federation, Israel, Mexico, Ukraine, Romania
-
Eli Lilly and CompanyRecruitingDiabetes Type 2United States, India, Mexico, Puerto Rico
-
Intarcia TherapeuticsTerminatedType 2 DiabetesUnited States
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes Mellitus | Renal ImpairmentUnited States, Russian Federation, Ukraine
-
Intarcia TherapeuticsCompletedType 2 DiabetesUnited States, Croatia, Latvia, Denmark, Germany
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesIsrael, Italy, United Kingdom, Denmark, Spain, Singapore, Taiwan, Germany, France, Hong Kong, Brazil
-
Deciphera Pharmaceuticals LLCActive, not recruitingTenosynovial Giant Cell Tumor | Giant Cell Tumor of Tendon Sheath | Pigmented Villonodular Synovitis | Tenosynovial Giant Cell Tumor, Diffuse | Tenosynovial Giant Cell Tumor, LocalizedNorway, United States, France, Spain, Hong Kong, Netherlands, Italy, Germany, Australia, United Kingdom, Canada, Poland, Switzerland
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes MellitusUnited States, Canada, Mexico
-
Concert PharmaceuticalsCompletedType 2 Diabetes Mellitus | Chronic Kidney DiseaseUnited States
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Lithuania, Netherlands, Puerto Rico, Romania, Slovakia, Sweden
-
AstraZenecaAstraZeneca, Bristol-Myers SquibbCompletedType 2 DiabetesChina, Korea, Republic of, Taiwan, India
-
Bristol-Myers SquibbMerck Sharp & Dohme LLCCompletedType 2 Diabetes MellitusUnited States, Argentina, Canada, Mexico, Peru, Taiwan, Australia, Philippines, Thailand, Brazil, Chile, India, Russian Federation, Ukraine
-
Biohaven Pharmaceuticals, Inc.Active, not recruitingSpinocerebellar Ataxias | Spinocerebellar Ataxia Genotype Type 1 | Spinocerebellar Ataxia Genotype Type 2 | Spinocerebellar Ataxia Genotype Type 3 | Spinocerebellar Ataxia Genotype Type 6 | Spinocerebellar Ataxia Genotype Type 7 | Spinocerebellar Ataxia Genotype Type 8 | Spinocerebellar Ataxia Genotype...United States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Australia, Hong Kong, Israel, New Zealand, Ukraine
-
GlaxoSmithKlineCompletedHypertensionUnited States
-
Fractyl Health Inc.RecruitingType 2 DiabetesUnited States, Ireland, United Kingdom, Belgium, Italy, Netherlands, Switzerland, Spain, France
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusSpain, Poland, South Africa, Taiwan, Hong Kong, Norway, Italy, Bulgaria, Latvia, Lithuania, Germany, Turkey, Argentina, Israel, Korea, Republic of, Dominican Republic, Guatemala, Brazil, Colombia, Peru, Philippines, Russian Federation and more
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Belgium, Hong Kong, United States, Germany, Portugal, Russian Federation, France, Canada, Finland, Austria, New Zealand, Spain, Poland, Thailand, Italy, Serbia, Korea, Republic of, Hungary, Mexico, Greece, Puerto Rico, Gu... and more